Functional Implications of Dopamine D2 Receptor Localization in Relation to Glutamate Neurons

Dopamine Handbook

Volumn , Issue , 2010, Pages

  Sesack, Susan R ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

D2; Dopamine receptors; Glut neurons; Prefrontal cortex

Indexed keywords

EID: 79960331755     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195373035.003.0003     Document Type: Chapter

References (186)

1. Schultz W. Multiple dopamine functions at different time courses. Annu Rev Neurosci. 2007;30:259-288.
2. Redgrave P, Gurney K, Reynolds J. What is reinforced by phasic dopamine signals? Brain Res Rev. 2008;58(2):322-339.
3. Liss B, Roeper J. Individual dopamine midbrain neurons: functional diversity and flexibility in health and disease. Brain Res Rev. 2008;58(2):314-321.
4. Cepeda C, Buchwald NA, Levine MS. Neuromodulatory actions of dopamine in the neostriatum are dependent on the excitatory amino acid receptor subtypes activated. Proc Natl Acad Sci USA. 1993;90(20):9576-9580.
5. Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol. 2004;74(1):1-58.
6. Zoli M, Torri C, Ferrari R, et al. The emergence of the volume transmission concept. Brain Res Rev. 1998;26(2-3): 136-147.
7. Descarries L, Berube-Carriere N, Riad M, Bo GD, Mendez JA, Trudeau LE. Glutamate in dopamine neurons: synaptic versus diffuse transmission. Brain Res Rev. 2008;58(2):290-302.
8. Rice ME, Cragg SJ. Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway. Brain Res Rev. 2008;58(2):303-313.
9. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev. 1998;78(1):189-225.
10. Smiley JF, Levey AI, Ciliax BJ, Goldman-Rakic PS. D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc Natl Acad Sci USA. 1994;91(12):5720-5724.
11. Bergson C, Mrzljak L, Smiley JF, Pappy M, Levenson R, Goldman-Rakic PS. Regional, cellular, and subcellular variations in the distribution of D1 and D5 receptors in primate brain. J Neurosci. 1995;15(12):7821-7836.
12. Hersch SM, Ciliax BJ, Gutekunst CA, et al. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci. 1995;15(7 pt 2):5222-5237.
13. Yung KK, Bolam JP, Smith AD, Hersch SM, Ciliax BJ, Levey AI. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience. 1995;65(3):709-730.
14. Yung KK, Bolam JP. Localization of dopamine D1 and D2 receptors in the rat neostriatum: synaptic interaction with glutamate- and GABA-containing axonal terminals. Synapse. 2000;38(4):413-420.
15. Paspalas CD, Goldman-Rakic PS. Microdomains for dopamine volume neurotransmission in primate prefrontal cortex. J Neurosci. 2004;24(23):5292-5300.
16. Paspalas CD, Goldman-Rakic PS. Presynaptic D1 dopamine receptors in primate prefrontal cortex: target-specific expression in the glutamatergic synapse. J Neurosci. 2005;25(5):1260-1267.
17. Hara Y, Pickel VM. Overlapping intracellular and differential synaptic distributions of dopamine D1 and glutamate N-methyl-d-aspartate receptors in rat nucleus accumbens. J Comp Neurol. 2005;492(4):442-455.
18. Pickel VM, Colago EE, Mania I, Molosh AI, Rainnie DG. Dopamine D1 receptors co-distribute with N-methyl-d-aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-d-aspartic acid currents in rat basolateral amygdala. Neuroscience. 2006;142(3):671-690.
19. Bordelon-Glausier JR, Khan ZU, Muly EC. Quantification of D1 and D5 dopamine receptor localization in layers I, III, and V of Macaca mulatta prefrontal cortical area 9: coexpression in dendritic spines and axon terminals. J Comp Neurol. 2008; 508(6):893-905.
20. Abi-Dargham A, Laruelle M. Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies. Eur Psychiatry. 2005;20(1):15-27.
21. Oades RD, Halliday GM. Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res Rev. 1987;12(2):117-165.
22. Fallon JH, Loughlin SE. Substantia nigra. In: Paxinos G, ed. The Rat Nervous System. 2nd ed. San Diego, CA: Academic Press; 1995:215-237.
23. Lewis DA, Sesack SR. Dopamine systems in the primate brain. In: Bloom FE, Björklund A, Hökfelt T, eds. Handbook of Chemical Neuroanatomy, The Primate Nervous System, Part I. Vol 13. Amsterdam: Elsevier Science Publishers; 1997:261-373.
24. Björklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends Neurosci. 2007;30(5):194-202.
25. Peretti-Renucci R, Feuerstein C, Manier M, et al. Quantitative image analysis with densitometry for immunohistochemistry and autoradiography of receptor binding sites--methodological considerations. J Neurosci Res. 1991;28(4):583-600.
26. Maggio JE, Mantyh PW. Autoradiography of reversible ligands. In: Ariano MA, ed. Receptor Localization: Laboratory Methods and Procedures New York, NY: Wiley-Liss; 1998:17-30.
27. Chesselet MF. Localization of mRNAs encoding receptors with in situ hybridization histochemistry. In: Ariano MA, ed. Receptor Localization: Laboratory Methods and Procedures. New York, NY: Wiley-Liss; 1998:140-159.
28. Stornetta RL, Guyenet PG. Nonradioactive in situ hybridization in combination with tract-tracing. In: Zaborszky L, Wouterlood FG, Lanciego JL, eds. Neuroanatomical Tract-Tracing 3: Molecules, Neurons, Systems. New York, NY: Springer; 2006:237-262.
29. Mathiisen TM, Nagelhus EA, Jouleh B, et al. Postembedding immunogold cytochemistry of membrane molecules and amino acid transmitters in the central nervous system. In: Zaborszky L, Wouterlood FG, Lanciego JL, eds. Neuroanatomical Tract-Tracing 3: Molecules, Neurons, Systems. New York, NY: Springer; 2006:72-108.
30. Sesack SR, Miner LAH, Omelchenko N. Pre-embedding immunoelectron microscopy: applications for studies of the nervous system. In: Zaborszky L, Wouterlood FG, Lanciego JL, eds. Neuroanatomical Tract-Tracing 3: Molecules, Neurons, Systems. New York, NY: Springer; 2006:6-71.
31. Surmeier DJ, Song W-J, Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci. 1996;16(20):6579-6591.
32. Eberwine J, Belt B, Kacharmina JE, Miyashiro K. Analysis of subcellularly localized mRNAs using in situ hybridization, mRNA amplification, and expression profiling. Neurochem Res. 2002;27(10):1065-1077.
33. Saper CB. Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry. J Comp Neurol. 2003;465(2):161-163.
34. Brey EM, Lalani Z, Johnston C, et al. Automated selection of DAB-labeled tissue for immunohistochemical quantification. J Histochem Cytochem. 2003;51(5):575-584.
35. Aizman O, Brismar H, Uhlen P, et al. Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nature Neurosci. 2000;3(3): 226-230.
36. Deng YP, Lei WL, Reiner A. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. J Chem. Neuroanat. 2006;32(2-4):101-116.
37. Levey A, Hersch S, Rye D, et al. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA. 1993;90(19):8861-8865.
38. Sesack SR, Aoki C, Pickel VM. Ultrastructural localization of D2 receptorlike immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci. 1994;14(1):88-106.
39. Somogyi P, Tamás G, Lujan R, Buhl EH. Salient features of synaptic organisation in the cerebral cortex. Brain Res Rev. 1998;26(2-3):113-135.
40. Mercuri NB, Saiardi A, Bonci A, et al. Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience. 1997;79(2):323-327.
41. Geisler S, Derst C, Veh RW, Zahm DS. Glutamatergic afferents of the ventral tegmental area in the rat. J Neurosci. 2007;27(21):5730-5743.
42. Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 1991;564(2):203-219.
43. Ariano MA, Fisher RS, Smyk-Randall E, Sibley DR, Levine MS. D2 dopamine receptor distribution in the rodent CNS using anti-peptide antibodies. Brain Res. 1993;609(1-2):71-80.
44. Meador-Woodruff JH, Damask SP, Watson SJ Jr. Differential expression of autoreceptors in the ascending dopamine systems of the human brain. Proc Natl Acad Sci USA. 1994;91(17):8297-8301.
45. Choi WS, Machida CA, Ronnekleiv OK. Distribution of dopamine D1, D2, and D5 receptor mRNAs in the monkey brain: ribonuclease protection assay analysis. Mol Brain Res. 1995; 31(1-2):86-94.
46. Khan ZU, Gutierrez A, Martin R, Penafiel A, Rivera A, De La Calle A. Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain. J Comp Neurol. 1998;402(3):353-371.
47. Pickel VM, Chan J, Nirenberg MJ. Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions. Synapse. 2002;45(2):113-124.
48. Tzschentke TM. Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol. 2001;63(3):241-320.
49. Kita H, Kitai ST. Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method. J Comp Neurol. 1987;260(3):435-452.
50. Omelchenko N, Sesack SR. Glutamate synaptic inputs to ventral tegmental area neurons in the rat derive primarily from subcortical sources. Neuroscience. 2007;146(3):1259-1274.
51. Bolam JP, Smith Y. The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat. Brain Res. 1990;529(1-2):57-78.
52. Kosinski CM, Standaert DG, Testa CM, Penney JB Jr, Young AB. Expression of metabotropic glutamate receptor 1 isoforms in the substantia nigra pars compacta of the rat. Neuroscience. 1998;86(3):783-798.
53. Chatha BT, Bernard V, Streit P, Bolam JP. Synaptic localization of ionotropic glutamate receptors in the rat substantia nigra. Neuroscience. 2000;101(4):1037-1051.
54. Rodriguez JJ, Doherty MD, Pickel VM. N-methyl-D-aspartate (NMDA) receptors in the ventral tegmental area: subcellular distribution and colocalization with 5-hydroxytryptamine(2A) receptors. J Neurosci Res. 2000;60(2):202-211.
55. Jones S, Kornblum JL, Kauer JA. Amphetamine blocks long-term synaptic depression in the ventral tegmental area. J Neurosci. 2000;20(15):5575-5580.
56. Thomas MJ, Malenka RC, Bonci A. Modulation of long-term depression by dopamine in the mesolimbic system. J Neurosci. 2000;20(15):5581-5586.
57. Sulzer D, Joyce MP, Lin L, et al. Dopamine neurons make glutamatergic synapses in vitro. J Neurosci. 1998;18(12):4588-4602.
58. Congar P, Bergevin A, Trudeau LE. D2 receptors inhibit the secretory process downstream from calcium influx in dopaminergic neurons: implication of K+ channels. J Neurophysiol. 2002;87(2):1046-1056.
59. Lavin A, Nogueira L, Lapish CC, Wightman RM, Phillips PE, Seamans JK. Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling. J Neurosci. 2005;25(20):5013-5023.
60. Kawano M, Kawasaki A, Sakata-Haga H, et al. Particular subpopulations of midbrain and hypothalamic dopamine neurons express vesicular glutamate transporter 2 in the rat brain. J Comp Neurol. 2006;498(5):581-592.
61. Yamaguchi T, Sheen W, Morales M. Glutamatergic neurons are present in the rat ventral tegmental area. Eur J Neurosci. 2007;25(1):106-118.
62. Nair-Roberts RG, Chatelain-Badie SD, Benson E, White-Cooper H, Bolam JP, Ungless MA. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience. 2008;152(4):1024-1031.
63. Fujiyama F, Kuramoto E, Okamoto K, et al. Presynaptic localization of an AMPA-type glutamate receptor in corticostriatal and thalamostriatal axon terminals. Eur J Neurosci. 2004;20(12):3322-3330.
64. Hur EE, Zaborszky L. Vglut2 afferents to the medial prefrontal and primary somatosensory cortices: a combined retrograde tracing in situ hybridization. J Comp Neurol. 2005; 483(3):351-373.
65. Dobi A, Morales M. Dopaminergic neurons in the rat ventral tegmental area (VTA) receive glutamatergic inputs from local glutamatergic neurons. Soc Neurosci Abstr. 2007:916-918.
66. Trudeau LE. Glutamate co-transmission as an emerging concept in monoamine neuron function. J Psychiatry Neurosci. 2004;29(4):296-310.
67. Lapish CC, Kroener S, Durstewitz D, Lavin A, Seamans JK. The ability of the mesocortical dopamine system to operate in distinct temporal modes. Psychopharmacology. 2007;191(3):609-625.
68. Goldman-Rakic PS, Leranth C, Williams SM, Mons N, Geffard M. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc Natl Acad Sci USA. 1989; 86(22):9015-9019.
69. Gasbarri A, Sulli A, Packard MG. The dopaminergic mesencephalic projections to the hippocampal formation in the rat. Prog Neuro-Psychopharm Biol Psychiatr. 1997;21(1):1-22.
70. Melchitzky DS, Erickson SL, Lewis DA. Dopamine innervation of the monkey mediodorsal thalamus: location of projection neurons and ultrastructural characteristics of axon terminals. Neuroscience. 2006;143(4):1021-1030.
71. Muller JF, Mascagni F, McDonald AJ. Dopaminergic innervation of pyramidal cells in the rat basolateral amygdala. Brain Struct Funct. 2009;213(3):275-288.
72. Smith Y, Kieval JZ. Anatomy of the dopamine system in the basal ganglia. Tr Neurosci. 2000;23(suppl 10):S28-S33.
73. Smith Y, Villalba R. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. 2008;23:S534-S547.
74. Svenningsson P, Le Moine C. Dopamine D1/5 receptor stimulation induces c-fos expression in the subthalamic nucleus: possible involvement of local D5 receptors. Eur J Neurosci. 2002;15(1):133-142.
75. Gaspar P, Bloch B, Le Moine C. D1 and D2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur J Neurosci. 1995; 7(5):1050-1063.
76. Meador-Woodruff JH, Damask SP, Wang JC, Haroutunian V, Davis KL, Watson SJ. Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology. 1996;15(1):17-29.
77. Lidow MS, Wang F, Cao Y, Goldman-Rakic PS. Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex. Synapse. 1998;28(1):10-20.
78. de Almeida J, Palacios JM, Mengod G. Distribution of 5-HT and DA receptors in primate prefrontal cortex: implications for pathophysiology and treatment. Prog Brain Res. 2008;172:101-115.
79. Eliava M, Yilmazer-Hanke D, Asan E. Interrelations between monoaminergic afferents and corticotropin-releasing factor-immunoreactive neurons in the rat central amygdaloid nucleus: ultrastructural evidence for dopaminergic control of amygdaloid stress systems. Histochem Cell Biol. 2003;120(3):183-197.
80. Rieck RW, Ansari MS, Whetsell WO Jr, Deutch AY, Kessler RM. Distribution of dopamine D2-like receptors in the human thalamus: autoradiographic and PET studies. Neuropsycho-pharmacology. 2004;29(2):362-372.
81. Awenowicz PW, Porter LL. Local application of dopamine inhibits pyramidal tract neuron activity in the rodent motor cortex. J Neurophysiol. 2002;88(6):3439-3451.
82. Negyessy L, Goldman-Rakic PS. Subcellular localization of the dopamine D2 receptor and coexistence with the calcium-binding protein neuronal calcium sensor-1 in the primate prefrontal cortex. J Comp Neurol. 2005;488(4):464-475.
83. Pinto A, Sesack SR. Ultrastructural analysis of prefrontal cortical inputs to the rat amygdala: spatial relationships to presumed dopamine axons and D1 and D2 receptors. Brain Struct Funct. 2008;213(1-2):159-175.
84. Khan ZU, Koulen P, Rubinstein M, Grandy DK, Goldman-Rakic PS. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. Proc Natl Acad Sci USA. 2001;98(4):1964-1969.
85. Agulhon C, Petravicz J, McMullen AB, et al. What is the role of astrocyte calcium in neurophysiology? Neuron. 2008;59(6): 932-946.
86. Kabbani N, Negyessy L, Lin R, Goldman-Rakic P, Levenson R. Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J Neurosci. 2002;22(19):8476-8486.
87. Paspalas CD, Rakic P, Goldman-Rakic PS. Internalization of D2 dopamine receptors is clathrin-dependent and select to dendro-axonic appositions in primate prefrontal cortex. Eur J Neurosci. 2006;24(5):1395-1403.
88. Pickel VM, Chan J, Kearn CS, Mackie K. Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J Comp Neurol. 2006;495(3):299-313.
89. Gulledge AT, Jaffe DB. Dopamine decreases the excitability of layer V pyramidal cells in the rat prefrontal cortex. J Neurosci. 1998;18(21):9139-9151.
90. Zheng P, Zhang XX, Bunney BS, Shi WX. Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine. Neuroscience. 1999;91(2):527-535.
91. Tseng KY, O'Donnell P. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J Neurosci. 2004;24(22):5131-5139.
92. Tseng KY, O'Donnell P. D2 dopamine receptors recruit a GABA component for their attenuation of excitatory synaptic transmission in the adult rat prefrontal cortex. Synapse. 2007;61(10):843-850.
93. Sun X, Zhao Y, Wolf ME. Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons. J Neurosci. 2005;25(32):7342-7351.
94. Kotecha SA, Oak JN, Jackson MF, et al. A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron. 2002;35(6):1111-1122.
95. Kroner S, Rosenkranz JA, Grace AA, Barrionuevo G. Dopamine modulates excitability of basolateral amygdala neurons in vitro. J Neurophysiol. 2005;93(3):1598-1610.
96. Rosenkranz JA, Johnston D. State-dependent modulation of amygdala inputs by dopamine-induced enhancement of sodium currents in layer V entorhinal cortex. J Neurosci. 2007; 27(26):7054-7069.
97. O'Donnell P. Dopamine gating of forebrain neural ensembles. Eur J Neurosci. 2003;17(3):429-435.
98. Tseng KY, O'Donnell P. Post-pubertal emergence of prefrontal cortical up states induced by D1-NMDA co-activation. Cereb Cortex. 2005;15(1):49-57.
99. 2+-dependent intracellular signaling. J Neurophysiol. 2007;97(3): 2448-2464.
100. Otani S, Blond O, Desce JM, Crepel F. Dopamine facilitates longterm depression of glutamatergic transmission in rat prefrontal cortex. Neuroscience. 1998;85(3):669-676.
101. Gurden H, Takita M, Jay TM. Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampalprefrontal cortex synapses in vivo. J Neurosci. 2000;20:RC106(22):1-5.
102. Gonzalez-Burgos G, Lewis DA. GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull. 2008;34(5):944-961.
103. Sesack SR, Snyder CL, Lewis DA. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol. 1995;363(2):264-280.
104. Pinard CR, Muller JF, Mascagni F, McDonald AJ. Dopaminergic innervation of interneurons in the rat basolateral amygdala. Neuroscience. 2008;157(4):850-863.
105. Gulledge AT, Jaffe DB. Multiple effects of dopamine on layer V pyramidal cell excitability in rat prefrontal cortex. J Neurophysiol. 2001;86(2):586-595.
106. Tseng KY, Mallet N, Toreson KL, Le Moine C, Gonon F, O'Donnell P. Excitatory response of prefrontal cortical fast-spiking interneurons to ventral tegmental area stimulation in vivo. Synapse. 2006;59(7):412-417.
107. Tseng KY, O'Donnell P. Dopamine modulation of prefrontal cortical interneurons changes during adolescence. Cereb Cortex. 2007;17(5):1235-1240.
108. Totterdell S, Smith AD. Convergence of hippocampal and dopaminergic input onto identified neurons in the nucleus accumbens of the rat. J Chem Neuroanat. 1989;2(5):285-298.
109. Sesack SR, Pickel VM. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol. 1992;320(2):145-160.
110. Yao WD, Spealman RD, Zhang J. Dopaminergic signaling in dendritic spines. Biochem Pharmacol. 2008;75(11):2055-2069.
111. Henze DA, Gonzalez-Burgos GR, Urban NN, Lewis DA, Barrionuevo G. Dopamine increases excitability of pyramidal neurons in primate prefrontal cortex. J Neurophysiol. 2000;84(6):2799-2809.
112. Moss J, Bolam JP. A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals. J Neurosci. 2008;28(44):11221-11230.
113. Boundy VA, Luedtke RR, Artymyshyn RP, Filtz TM, Molinoff PB. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides. Mol Pharmacol. 1993;43(5):666-676.
114. Fisher RS, Levine MS, Sibley DR, Ariano MA. D2 dopamine receptor protein localization: golgi impregnation-gold toned and ultrastructural analysis of the rat neostriatum. J Neurosci Res. 1994;38(5):551-564.
115. Mengual E, Pickel VM. Ultrastructural immunocytochemical localization of the dopamine D2 receptor and tyrosine hydroxylase in the rat ventral pallidum. Synapse. 2002;43(3):151-162.
116. Delle Donne KT, Sesack SR, Pickel VM. Ultrastructural immunocytochemical localization of neurotensin and the dopamine D2 receptor in the rat nucleus accumbens. J Comp Neurol. 1996;371(4):552-566.
117. Aubert I, Ghorayeb I, Normand E, Bloch B. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum. J Comp Neurol. 2000;418(1):22-32.
118. Alcantara AA, Chen V, Herring BE, Mendenhall JM, Berlanga ML. Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat. Brain Res. 2003;986(1-2):22-29.
119. Gerfen CR, Engber TM, Mahan LC, et al. D1 and D2 dopamine receptor regulated gene expression of striatonigral and striatopallidal neurons. Science. 1990;250(4986):1429-1432.
120. Le Moine C, Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol. 1995;355(3):418-426.
121. Delle Donne KT, Sesack SR, Pickel VM. Ultrastructural immunocytochemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum. Brain Res. 1997; 746(1-2):239-255.
122. Surmeier DJ, Eberwine J, Wilson CJ, Cao Y, Stefani A, Kitai ST. Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc Natl Acad Sci USA. 1992;89(21):10178-10182.
123. Surmeier DJ, Reiner A, Levine MS, Ariano MA. Are neostriatal dopamine receptors co-localized? Trends Neurosci. 1993;16(8):299-305.
124. Le Moine C, Bloch B. Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors. Neuroscience. 1996;73(1):131-143.
125. Parent A, Sato F, Wu Y, Gauthier J, Levesque M, Parent M. Organization of the basal ganglia: the importance of axonal collateralization. Trends Neurosci. 2000;23(suppl 10): S20-S27.
126. Day M, Wang Z, Ding J, et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci. 2006;9(2):251-259.
127. Lee KW, Kim Y, Kim AM, Helmin K, Nairn AC, Greengard P. Cocaineinduced dendritic spine formation in D1 and D2 dopamine receptorcontaining medium spiny neurons in nucleus accumbens. Proc Natl Acad Sci USA. 2006;103(9):3399-3404.
128. Wang Z, Kai L, Day M, et al. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron. 2006;50(3):443-452.
129. Delle Donne KT, Chan J, Boudin H, Pelaprat D, Rostene W, Pickel VM. Electron microscopic dual labeling of high-affinity neurotensin and dopamine D2 receptors in the rat nucleus accumbens shell. Synapse. 2004;52(3):176-187.
130. Hernández-Echeagaray E, Starling AJ, Cepeda C, Levine MS. Modulation of AMPA currents by D2 dopamine receptors in striatal medium-sized spiny neurons: are dendrites necessary? Eur J Neurosci. 2004;19(9):2455-2463.
131. Surmeier DJ, Ding J, Day M, Wang Z, Shen W. D1 and D2 dopaminereceptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 2007;30(5):228-235.
132. Smith AD, Bolam JP. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci. 1990;13(7):259-265.
133. Bernard V, Somogyi P, Bolam JP. Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat. J Neurosci. 1997;17(2):819-833.
134. Guigoni C, Doudnikoff E, Li Q, Bloch B, Bezard E. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates. Neurobiol Dis. 2007;26(2):452-463.
135. Wang H, Pickel VM. Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J Comp Neurol. 2002;442(4): 392-404.
136. 2+ channels in the proximal versus distal dendrites to synaptic integration in prefrontal cortical neurons. J Neurosci. 1997;17(15):5936-5948.
137. Ehlers MD, Heine M, Groc L, Lee MC, Choquet D. Diffusional trapping of GluR1 AMPA receptors by input-specific synaptic activity. Neuron. 2007;54(3):447-460.
138. Wolf ME, Mangiavacchi S, Sun X. Mechanisms by which dopamine receptors may influence synaptic plasticity. Ann NY Acad Sci. 2003;1003:241-249.
139. Lei W, Jiao Y, Del Mar N, Reiner A. Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats. J Neurosci. 2004;24(38):8289-8299.
140. Cepeda C, Andre VM, Yamazaki I, Wu N, Kleiman-Weiner M, Levine MS. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons. Eur J Neurosci. 2008;27(3):671-682.
141. Shen W, Flajolet M, Greengard P, Surmeier DJ. Dichotomous dopaminergic control of striatal synaptic plasticity. Science. 2008;321(5890):848-851.
142. Stephens B, Mueller AJ, Shering AF, et al. Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience. 2005;132(3):741-754.
143. Ingham CA, Hood SH, Taggart P, Arbuthnott GW. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J Neurosci. 1998;18(12): 4732-4743.
144. Villalba RM, Lee H, Smith Y. Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys. Exp Neurol. 2008;215(2):220-227.
145. Solis O, Limon DI, Flores-Hernandez J, Flores G. Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease. Synapse. 2007;61(6):450-458.
146. Smythies J. Redox mechanisms at the glutamate synapse and their significance: a review. Eur J Pharmacol. 1999;370(1):1-7.
147. Kihara T, Shimohama S, Sawada H, et al. Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade. J Neurosci Res. 2002;70(3):274-282.
148. Wang HD, Deutch AY. Dopamine depletion of the prefrontal cortex induces dendritic spine loss: reversal by atypical antipsychotic drug treatment. Neuropsychopharmacology. 2008;33(6): 1276-1286.
149. Pierce JP, Lewin GR. An ultrastructural size principle. Neuroscience. 1994;58(3):441-446.
150. Sorra KE, Fiala JC, Harris KM. Critical assessment of the involvement of perforations, spinules, and spine branching in hippocampal synapse formation. J Comp Neurol. 1998;398(2): 225-240.
151. Meshul CK, Stallbaumer RK, Taylor B, Janowsky A. Haloperidol-induced morphological changes in striatum are associated with glutamate synapses. Brain Res. 1994; 648(2): 181-195.
152. Meshul CK, Janowsky A, Casey DE, Stallbaumer RK, Taylor B. Coadministration of haloperidol and SCH-23390 prevents the increase in "perforated" synapses due to either drug alone. Neuropsychopharmacology. 1992;7(4):285-293.
153. Robinson TE, Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology. 2004;47(suppl 1): 33-46.
154. Bamford NS, Zhang H, Schmitz Y, et al. Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron. 2004;42(4):653-663.
155. Yang CR, Mogenson GJ. Dopamine enhances terminal excitability of hippocampal-accumbens neurons via D2 receptor: role of dopamine in presynaptic inhibition. J Neurosci. 1986;6(8):2470-2478.
156. O'Donnell P, Grace AA. Tonic D2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro. Brain Res. 1994;634(1):105-112.
157. Cepeda C, Hurst RS, Altemus KL, et al. Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol. 2001;85(2):659-670.
158. Rosenkranz JA, Grace AA. Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J Neurosci. 2001;21(11):4090-4103.
159. Yin HH, Lovinger DM. Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc Natl Acad Sci USA. 2006; 103(21):8251-8256.
160. Koga E, Momiyama T. Presynaptic dopamine D2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones. J Physiol. 2000;523(pt 1):163-173.
161. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 1990;347(6289):146-151.
162. Lévesque D, Martres MP, Diaz J, et al. A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc Natl Acad Sci USA. 1995;92(5):1719-1723.
163. Levant B. The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev. 1997;49(3):231-252.
164. Heidbreder CA, Gardner EL, Xi ZX, et al. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Rev. 2005;49(1):77-105.
165. Ariano AA, Sibley DR. Dopamine receptor distribution in the rat CNS: elucidation using anti-peptide antisera directed against D1A and D3 subtypes. Brain Res. 1994;649(1-2):95-110.
166. Diaz J, Levesque D, Lammers CH, et al. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience. 1995;65(3):731-745.
167. Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Sedvall G. D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res. 1998;779(1-2):58-74.
168. Diaz J, Pilon C, Le Foll B, et al. Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci. 2000;20(23):8677-8684.
169. Stanwood GD, Artymyshyn RP, Kung MP, Kung HF, Lucki I, McGonigle P. Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. J Pharmacol Exp Ther. 2000;295(3):1223-1231.
170. Koeltzow TE, Xu M, Cooper DC, et al. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J Neurosci. 1998;18(6):2231-2238.
171. Le Foll B, Diaz J, Sokoloff P. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice. Life Sci. 2005;76(11):1281-1296.
172. Van Tol HH, Bunzow JR, Guan HC, et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 1991;350(6319): 610-614.
173. Mrzljak L, Bergson C, Pappy M, Huff R, Levenson R, Goldman-Rakic PS. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature. 1996;381(6579): 245-248.
174. Avale ME, Falzone TL, Gelman DM, Low MJ, Grandy DK, Rubinstein M. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Mol Psychiatry. 2004;9(7):718-726.
175. Ariano MA, Wang J, Noblett KL, Larson ER, Sibley DR. Cellular distribution of the rat D4 dopamine receptor protein in the CNS using antireceptor antisera. Brain Res. 1997; 752(1-2):26-34.
176. Wędzony K, Chocyk A, Maćkowiak M, Fijał K, Czyrak A. Cortical localization of dopamine D4 receptors in the rat brain-immunocytochemical study. J Physiol Pharmacol. 2000;51(2):205-221.
177. Berger MA, Defagot MC, Villar MJ, Antonelli MC. D4 dopamine and metabotropic glutamate receptors in cerebral cortex and striatum in rat brain. Neurochem Res. 2001;26(4): 345-352.
178. Rivera A, Cuellar B, Giron FJ, Grandy DK, de la Calle A, Moratalla R. Dopamine D4 receptors are heterogeneously distributed in the striosomes/ matrix compartments of the striatum. J Neurochem. 2002;80(2):219-229.
179. Rivera A, Peñafiel A, Megías M, et al. Cellular localization and distribution of dopamine D(4) receptors in the rat cerebral cortex and their relationship with the cortical dopaminergic and noradrenergic nerve terminal networks. Neuroscience. 2008;155(3):997-1010.
180. Svingos AL, Periasamy S, Pickel VM. Presynaptic dopamine D4 receptor localization in the rat nucleus accumbens shell. Synapse. 2000;36(3):222-232.
181. Noain D, Avale ME, Wedemeyer C, Calvo D, Peper M, Rubinstein M. Identification of brain neurons expressing the dopamine D4 receptor gene using BAC transgenic mice. Eur J Neurosci. 2006;24(9):2429-2438.
182. Martina M, Bergeron R. D1 and D4 dopaminergic receptor interplay mediates coincident G protein-independent and dependent regulation of glutamate NMDA receptors in the lateral amygdala. J Neurochem. 2008; 106(6):2421-2435.
183. Wang X, Zhong P, Gu Z, Yan Z. Regulation of NMDA receptors by dopamine D4 signaling in prefrontal cortex. J Neurosci. 2003;23(30):9852-9861.
184. Onn SP, Wang XB, Lin M, Grace AA. Dopamine D1 and D4 receptor subtypes differentially modulate recurrent excitatory synapses in prefrontal cortical pyramidal neurons. Neuropsychopharmacology. 2006;31(2): 318-338.
185. Wang X, Zhong P, Yan Z. Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. J Neurosci. 2002;22(21):9185-9193.
186. Rubinstein M, Cepeda C, Hurst RS, et al. Dopamine D4 receptor-deficient mice display cortical hyperexcitability. J Neurosci. 2001;21(11):3756-3763.